Double or triple down: how AFT Pharmaceuticals plans to win in China

Double or triple down: how AFT Pharmaceuticals plans to win in China
(Image: Getty)
Rebecca Stevenson
AFT Pharmaceuticals says it has increased manufacturing capacity and brought in market experts as it prepares to launch its antibacterial cream in China. The New Zealand Exchange-listed (NZX) firm reported its results for the 12 months to March 31 on May 23. Its international and Asian sales rose 70%, accounting for 20% of revenue. Operating revenue for AFT’s Asian business grew 57% to $10.7 million from $6.8m, while operating profit rose to $2.5m from $900,000.It said growth was driven through the hospital channel, wi...

More Markets

Skellerup CEO: 'We had too many records, so we dropped one'
Markets

Skellerup CEO: 'We had too many records, so we dropped one'

They're buying Skellerup's teats all over, not just in NZ.

Fonterra lifts previous season's milk price
Primary Sector

Fonterra lifts previous season's milk price

It's narrowed the range on the current season.

SkyCity pushes ahead with $240m raise despite Allan Gray warning
Markets

SkyCity pushes ahead with $240m raise despite Allan Gray warning

CEO Jason Walbridge says an equity raise is in the interests of all shareholders.